Review on clinical trials of targeted treatments in malignant mesothelioma Jan Nyrop JakobsenJens Benn Sørensen Mini Review 07 May 2011 Pages: 1 - 15
Cryptotanshinone has diverse effects on cell cycle events in melanoma cell lines with different metastatic capacity Lei ChenShi-zhong ZhengYin Lu Original Article 04 September 2010 Pages: 17 - 27
Can localised 19F magnetic resonance spectroscopy pharmacokinetics of 5FU in colorectal metastases predict clinical response? Dominick J. O. McIntyreFranklyn A. HoweJohn R. Griffiths Original Article Open access 07 September 2010 Pages: 29 - 36
Pegylated liposomal doxorubicin, 5-fluorouracil and cisplatin versus mitomycin-C, 5-fluorouracil and cisplatin for advanced gastric cancer: a randomized phase II trial Stefano CascinuEva GaliziaMario Scartozzi Original Article 07 September 2010 Pages: 37 - 43
In vitro and in vivo antitumor effects of (4-methoxyphenyl)(3,4,5-trimethoxyphenyl)methanone Hemerson Iury F. MagalhãesDaniel P. BezerraClaudia Pessoa Original Article 07 September 2010 Pages: 45 - 52
Pharmacokinetic results of a phase I trial of sorafenib in combination with dacarbazine in patients with advanced solid tumors Erich BrendelMatthias LudwigJean-Pierre Armand Original Article Open access 07 September 2010 Pages: 53 - 61
Α multicenter phase II study of pegylated liposomal doxorubicin in combination with irinotecan as second-line treatment of patients with refractory small-cell lung cancer Nikolaos XenidisNikolaos VardakisVassilis Georgoulias Original Article 10 September 2010 Pages: 63 - 68
Efficacy and safety of motesanib, an oral inhibitor of VEGF, PDGF, and Kit receptors, in patients with imatinib-resistant gastrointestinal stromal tumors Robert S. BenjaminPatrick SchöffskiLaurence Baker Original Article Open access 14 September 2010 Pages: 69 - 77
Kinase activation profile associated with TGF-β-dependent migration of HCC cells: a preclinical study Emilia FransveaAntonio MazzoccaGianluigi Giannelli Original Article 16 September 2010 Pages: 79 - 86
Interleukin-1 receptor antagonist reduced apoptosis and attenuated intestinal mucositis in a 5-fluorouracil chemotherapy model in mice Zhen-Qian WuXiao-Dong HanQi Zheng Original Article 16 September 2010 Pages: 87 - 96
Sensitivity and gene expression profile of fresh human acute myeloid leukemia cells exposed ex vivo to AS602868 Lars Petter JordheimAdriana PlesaCharles Dumontet Original Article 16 September 2010 Pages: 97 - 105
Hyaluronic acid–paclitaxel: effects of intraperitoneal administration against CD44(+) human ovarian cancer xenografts Ilaria De StefanoAlessandra BattagliaDaniela Gallo Original Article 17 September 2010 Pages: 107 - 116
Synergistic interactions between peloruside A and other microtubule-stabilizing and destabilizing agents in cultured human ovarian carcinoma cells and murine T cells Anja WilmesDavid O’SullivanJohn H. Miller Original Article 17 September 2010 Pages: 117 - 126
Novel small molecule drugs inhibit tumor cell metabolism and show potent anti-tumorigenic potential Christina Trojel-HansenKamille Dumong ErichsenSøren Jensby Nielsen Original Article 18 September 2010 Pages: 127 - 138
Multimodal therapy for liver cirrhosis patients with advanced hepatocellular carcinoma Hidenari NagaiTeppei MatsuiYasukiyo Sumino Original Article 21 September 2010 Pages: 139 - 145
Changes induced by surgical and clinical factors in the pharmacology of intraperitoneal mitomycin C in 145 patients with peritoneal carcinomatosis Kurt Van der SpeetenO. Anthony StuartPaul H. Sugarbaker Original Article 21 September 2010 Pages: 147 - 156
A phase I/II study of gemcitabine-based chemotherapy plus curcumin for patients with gemcitabine-resistant pancreatic cancer Masashi KanaiKenichi YoshimuraBharat B. Aggarwal Original Article 22 September 2010 Pages: 157 - 164
Prognostic implication of 18F FDG-PET in patients with extrahepatic metastatic hepatocellular carcinoma undergoing systemic treatment, a retrospective cohort study Dong-Yeop ShinSae-Won HanYung-Jue Bang Original Article 25 September 2010 Pages: 165 - 175
Docetaxel/cisplatin followed by FOLFIRI versus the reverse sequence in metastatic gastric cancer Jung A. KimJeeyun LeeWon Ki Kang Original Article 28 September 2010 Pages: 177 - 184
Difluorodeoxyuridine plasma concentrations after low-dose gemcitabine during chemoradiation in head and neck cancer patients P. SpecenierG. GuetensJ. B. Vermorken Original Article 30 September 2010 Pages: 185 - 191
Preclinical toxicity and toxicokinetics of GTI-2040, a phosphorothioate oligonucleotide targeting ribonucleotide reductase R2 Eckhardt S. FerdinandiAikaterini VassilakosAiping H. Young Original Article 01 October 2010 Pages: 193 - 205
Lentivirus-mediated inhibition of Med19 suppresses growth of breast cancer cells in vitro Li-Hua LiJie HeQi Gao Original Article 02 October 2010 Pages: 207 - 215
Salvage treatment in metastatic breast cancer with weekly paclitaxel and bevacizumab Aris PolyzosKostas KalbakisDimitris Mavroudis Original Article 05 October 2010 Pages: 217 - 223
Sandostatin desensitization–a strategy useful for patients with carcinoid tumors, intolerant to sandostatin Sanjay VinjamaramRenuka Iyer Original Article 05 October 2010 Pages: 225 - 226
Inhibition of N-linked glycosylation by tunicamycin induces E-cadherin-mediated cell–cell adhesion and inhibits cell proliferation in undifferentiated human colon cancer cells Julio Cesar Madureira de Freitas JuniorBárbara Du Rocher D’Aguiar SilvaJosé Andrés Morgado-Díaz Original Article 07 October 2010 Pages: 227 - 238
High-performance liquid chromatographic method for the determination of sorafenib in human serum and peritoneal fluid Werner J. HeinzKathrin KahleHartwig Klinker Original Article 07 October 2010 Pages: 239 - 245
Phase I clinical trial of hepatic arterial infusion of paclitaxel in patients with advanced cancer and dominant liver involvement Apostolia M. TsimberidouKatherine LetourneauRazelle Kurzrock Original Article 13 October 2010 Pages: 247 - 253
Phase I trial of capecitabine plus everolimus (RAD001) in patients with previously treated metastatic gastric cancer Taekyu LimJeeyun LeeWon Ki Kang Clinical Trial Report Open access 28 April 2011 Pages: 255 - 262
Pharmacokinetics of oxaliplatin in a hemodialytic patient treated with modified FOLFOX-6 plus bevacizumab therapy Takahiro HorimatsuShin’ichi MiyamotoTsutomu Chiba Short Communication 16 April 2011 Pages: 263 - 266
Neoadjuvant intraperitoneal chemotherapy with paclitaxel for the radical surgical treatment of peritoneal carcinomatosis in ovarian cancer: a prospective pilot study Francisco C. Muñoz-CasaresSebastián RufiánEnrique Aranda Short Communication 17 April 2011 Pages: 267 - 274
